Sight Sciences Get Rating News Today

Sight Sciences (NASDAQ:SGHT – Get Rating) is one of 216 public companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare Sight Sciences to similar companies based on the strength of its earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and risk. Valuation and […]

Nuvectra (OTCMKTS:NVTRQ – Get Rating) and Sight Sciences (NASDAQ:SGHT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Analyst Recommendations This is a summary of current ratings and […]

Sight Sciences (NASDAQ:SGHT – Get Rating) announced its earnings results on Thursday. The company reported ($0.34) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.39) by $0.05, Fidelity Earnings reports. Sight Sciences updated its FY 2022 guidance to EPS. Shares of SGHT opened at $13.46 on Friday. The company has a debt-to-equity […]